
How Antibody Engineering Minimizes Immunogenicity in Biologics
How does Antibody Engineering minimize immunogenicity? It enhances biologic safety and performance. Partner with Precision Antibody today!
Home » News

How does Antibody Engineering minimize immunogenicity? It enhances biologic safety and performance. Partner with Precision Antibody today!

How do screening and characterization aid therapeutic validation? Ensure efficacy, avoid pitfalls, and accelerate drug success.

Which antibody format fits your pipeline – fully human or humanized? Compare safety, efficacy & speed. Partner with Precision Antibody today!

As the field of immunology has evolved, researchers have developed new and improved methods of producing antibodies. Fully human monoclonal antibody development is one such

What Are Fully Human Monoclonal Antibodies? Totally human monoclonal antibody (mAbs) have emerged as one of the most effective weapons in the fight against complicated

How do antibodies stay stable from cell line to clinic? Explore antibody production best practices and scale-up strategies. Read more now!

Internalization assays play a vital role in antibody research and development by allowing scientists to investigate the uptake and intracellular trafficking of antibodies. These assays

Which assay is right for your antibody – ELISA, Flow, or Western? Compare uses and enhance research with Precision Antibody today!

Columbia, Maryland – Dr. Ginette Serrero, CEO of A&G Pharmaceutical Inc., DBA Precision Antibody, will present two posters at the American Association of Cancer Research’s

Compare custom vs. off-the-shelf antibodies to find the best fit for your drug program based on specificity, cost, scalability, and long-term success.
Precision Antibody™ is the forefront of the global Custom Antibody industry & it is led by the innovative minds in immunology and antibody development field.